Target intelligence / Profile preview

Trans-2,3-dihydro-3-hydroxyanthranilate isomerase (PhzF)

Target
PhzF
Molecular classification
Enzyme
01

Overview

Trans-2,3-dihydro-3-hydroxyanthranilate isomerase is a bacterial enzyme (EC 5.3.3.17), also known by the gene name PhzF, that catalyzes the isomerization of (5S,6S)-6-amino-5-hydroxycyclohexane-1,3-diene-1-carboxylate during the biosynthetic pathway that produces phenazine compounds. Phenazines, such as pyocyanin, play roles in microbial competition, virulence, and redox homeostasis in bacteria including Pseudomonas and Streptomyces species[3][4][5][6][9][10]. This enzyme is critical for bacteria to produce phenazine secondary metabolites, which can exhibit antibiotic, antitumor, and antiparasitic activity, and act as virulence factors in pathogenic bacteria. It is not a direct human receptor or therapeutic target but may be of interest in developing novel antibacterial strategies by inhibiting phenazine biosynthesis[9].

Other names
PhzF (gene name)(5S,6S)-6-amino-5-hydroxycyclohexane-1,3-diene-1-carboxylate isomerase
02

Biological functions

Phenazine biosynthesisTryptophan biosynthesis (in bacteria)Condensation/isomerization of aromatic metabolites
03

Disease associations

Infection (phenazine products are virulence factors in Pseudomonas infections)Other (not a direct human therapeutic target, but indirectly relevant via bacterial virulence)

Beyond the preview

Go deeper on Trans-2,3-dihydro-3-hydroxyanthranilate isomerase (PhzF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trans-2,3-dihydro-3-hydroxyanthranilate isomerase (PhzF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call